Filter
587
Text search:
pharmaceutical
quality
control
laboratories
Featured
Recommendations
57
New Publications
177
Language
Document type
No document type
287
Studies & Reports
120
Guidelines
96
Strategic & Response Plan
43
Manuals
27
Training Material
5
Situation Updates
5
Fact sheets
3
Resource Platforms
1
Countries / Regions
India
33
Kenya
31
Ethiopia
24
Nigeria
19
South Africa
17
Ghana
14
Western and Central Europe
14
Uganda
12
Sierra Leone
11
Liberia
11
Nepal
11
Tanzania
11
Malawi
11
Global
11
Bangladesh
9
Africa
9
Eastern Europe
9
Philippines
8
Cambodia
8
Zambia
7
Rwanda
7
Ukraine
7
Burkina Faso
6
Zimbabwe
6
Namibia
6
Latin America and the Carribbean
6
Syria
5
Eswatini/ Swaziland
5
Myanmar / Burma
5
Thailand
4
Indonesia
4
Lesotho
4
South–East Asia Region
4
Senegal
3
Pakistan
3
Botswana
3
Vietnam
3
Cameroon
2
Haiti
2
Benin
2
East and Southern Africa
2
West and Central Africa
2
Asia
2
Venezuela
2
Albania
2
Laos
2
Guinea
1
Congo, Democratic Republic of
1
Mali
1
USA
1
Saudi Arabia
1
Somalia
1
Iraq
1
Jordan
1
Afghanistan
1
China
1
Mozambique
1
Papua New Guinea
1
Sudan
1
Peru
1
North Macedonia
1
El Salvador
1
Western Pacific Region
1
Timor Leste/ East Timor
1
Tajikistan
1
Moldova
1
Iran
1
North America
1
Gabon
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
282
Key Resources
29
Clinical Guidelines
24
Pharmacy & Technologies
18
Public Health
15
Women & Child Health
10
Capacity Building
4
Toolboxes
AMR
114
COVID-19
44
Pharmacy
43
TB
38
Rapid Response
21
Mental Health
14
NTDs
14
HIV
13
2.0 Rapid Response
11
Conflict
10
Malaria
10
Planetary Health
9
Caregiver
7
Health Financing Toolbox
7
Ebola & Marburg
6
Polio
5
Global Health Education
5
Natural Hazards
4
Specific Hazards
3
NCDs
3
Cholera
2
Refugee
2
Zika
1
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine
...
Accessed: 02.05.2020
These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Develop
...
Antimicrobial resistance (AMR) is occurring everywhere in the world, compromising the ability to treat infectious diseases, as well as undermining many other advances in health and medicine. Underlying factors that drive AMR include; weak or absent surveillance and monitoring systems, inadequate sys
...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP
...
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and
...
Nosocomial or health-facility-acquired infections are a serious issue, representing one of the most significant causes of morbidity and mortality in healthcare systems and consuming many scarce resources, especially in developing countries. Although much has been done, particularly in the hospital s
...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients
...
Antimicrobial resistance (AMR) is a global public health crisis that resulted in 1.14 million deaths in 2021. According to the Institute for Health Metrics and Evaluation estimates, 96 416 of these deaths occurred in the World Health Organization (WHO) Eastern Mediterranean Region. All 22 countr
...
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety,
...
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...